University of Chicago Medicine Comprehensive Cancer Center
Chicago, Illinois, 60637, United States
NCT Number: NCT05886764
This trial will study different outreach methods to assess impact on enrollment of underrepresented minorities (specifically African Americans) to early phase cancer clinical treatment trials. Both patients and providers (those seeing enrolled patients) will be enrolled and receive the study interventions or no intervention (control arm).
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Chicago, Illinois, 60637, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Patient Subjects:
Inclusion criteria
for Provider Subjects:
Exclusion criteria
for Patient Subjects:
Digital messages (email, text, etc.) which include general educational information about clinical trials and available resources.
Invitation to contact a Community Ambassador for further information and support in the decision to participate in a clinical trial.
Time frame: within 2 months of randomization
Time frame: after 30 participants are enrolled to each of arms 2 and 3
Time frame: 2 years from randomization
Time frame: 2 years after study start
University of Chicago
Other
Randomized Trial of Recruitment Strategies for Early Phase Therapeutic Cancer Trials
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05770102
Cancer, Colonic Diseases
Belfast, United Kingdom
View Trial DetailsNCT05770544
Brain Diseases, Brain Neoplasms
Belfast, United Kingdom
View Trial DetailsNCT06988475
Cancer, Digestive System Diseases
Belfast, United Kingdom
View Trial DetailsNCT04495530
Cancer, End Stage Cancer
London, United Kingdom
View Trial Details